Actively Recruiting
Evaluating AI-Guided Cognitive Behavioral Therapy for Adults With Mild Depression and Anxiety Disorders
Led by Aleksandra Stojanovic · Updated on 2026-05-08
120
Participants Needed
1
Research Sites
3 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of an artificial intelligence AI-guided cognitive behavioral therapy CBT program for adults with mild depression and anxiety disorders. These mental health conditions are widespread and burdensome, yet access to psychotherapy is limited. This controlled clinical trial aims to compare AI-guided CBT with standard psychiatric care to explore how AI might improve access to and delivery of mental health treatment. Participants will be assigned to one of two groups an experimental group receiving AI-guided CBT through a digital platform, and a control group receiving standard psychiatric care. The AI-guided CBT involves structured weekly sessions lasting 45 to 60 minutes over 10 weeks, conducted under clinical supervision. The control group will receive routine clinical monitoring and treatment as determined by their clinician without access to the AI intervention. During the study, participants will undergo assessments at the start, mid-treatment week 5, and after treatment completion week 10. Researchers will measure changes in depression and anxiety symptoms, perceived stress, social support, digital therapeutic alliance, and overall clinical improvement. Data collection involves standardized scales and clinical impression assessments. Participants will provide informed consent, and data will be handled following ethical and privacy standards.
CONDITIONS
Brief Title
AI-Guided CBT for Depression and Anxiety
Research Team
A
Aleksandra Stojanovic, MD, PhD Candidate
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here